Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 9
1964 6
1965 2
1966 6
1967 2
1968 4
1969 1
1970 2
1971 4
1972 11
1973 9
1974 15
1975 13
1976 17
1977 11
1978 11
1979 10
1980 15
1981 10
1982 18
1983 11
1984 8
1985 6
1986 11
1987 11
1988 8
1989 16
1990 18
1991 9
1992 6
1993 8
1994 5
1995 2
1996 6
1997 9
1998 5
1999 4
2000 1
2001 5
2002 4
2003 4
2004 6
2005 5
2006 2
2007 2
2008 4
2009 5
2010 7
2011 2
2012 7
2013 5
2014 1
2015 5
2017 1
2018 5
2019 8
2020 7
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

408 results
Results by year
Filters applied: . Clear all
Page 1
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP. Lambert PH, et al. Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, Van Braeckel E, Ward BJ, Didierlaurent AM, Lambert PH; Brighton Collaboration Vaccine-associated Enhanced Disease Working Group. Munoz FM, et al. Among authors: lambert ph. Vaccine. 2021 May 21;39(22):3053-3066. doi: 10.1016/j.vaccine.2021.01.055. Epub 2021 Feb 23. Vaccine. 2021. PMID: 33637387 Free PMC article. Review.
Immunosuppressive agents.
Gerebtzoff A, Lambert PH, Miescher PA. Gerebtzoff A, et al. Among authors: lambert ph. Annu Rev Pharmacol. 1972;12:287-316. doi: 10.1146/annurev.pa.12.040172.001443. Annu Rev Pharmacol. 1972. PMID: 4556943 Review. No abstract available.
New vaccines for tuberculosis.
Kaufmann SH, Hussey G, Lambert PH. Kaufmann SH, et al. Among authors: lambert ph. Lancet. 2010 Jun 12;375(9731):2110-9. doi: 10.1016/S0140-6736(10)60393-5. Epub 2010 May 18. Lancet. 2010. PMID: 20488515 Review.
New vaccines against tuberculosis.
Lambert PH, Hawkridge T, Hanekom WA. Lambert PH, et al. Clin Chest Med. 2009 Dec;30(4):811-26, x. doi: 10.1016/j.ccm.2009.08.014. Clin Chest Med. 2009. PMID: 19925969 Review.
Towards vaccine optimisation.
Lussow AR, Aguado MT, Del Giudice G, Lambert PH. Lussow AR, et al. Among authors: lambert ph. Immunol Lett. 1990 Aug;25(1-3):255-63. doi: 10.1016/0165-2478(90)90124-9. Immunol Lett. 1990. PMID: 2283156 Review.
Novel vaccine safety issues and areas that would benefit from further research.
Salmon DA, Lambert PH, Nohynek HM, Gee J, Parashar UD, Tate JE, Wilder-Smith A, Hartigan-Go KY, Smith PG, Zuber PLF. Salmon DA, et al. Among authors: lambert ph. BMJ Glob Health. 2021 May;6(Suppl 2):e003814. doi: 10.1136/bmjgh-2020-003814. BMJ Glob Health. 2021. PMID: 34011502 Free PMC article. Review.
Advanced vaccinology education: Landscaping its growth and global footprint.
Asturias EJ, Duclos P, MacDonald NE, Nohynek H, Lambert PH; Global Vaccinology Training Collaborative. Asturias EJ, et al. Among authors: lambert ph. Vaccine. 2020 Jun 19;38(30):4664-4670. doi: 10.1016/j.vaccine.2020.05.038. Epub 2020 May 29. Vaccine. 2020. PMID: 32475535 Free PMC article.
408 results